Imagio Breast Imaging System
Overview
The Imagio® Breast Imaging System by Seno Medical Instruments is an innovative medical imaging modality that combines laser light and conventional ultrasound technology (Opto-Acoustic/Ultrasound or OA/US) to provide real-time functional and anatomical images of the breast. This system is designed to aid clinicians in differentiating between malignant and benign breast tissue by revealing information about blood and oxygen concentration, which are key indicators of cancer. It integrates an AI-driven clinical decision support tool called SenoGram®, which assists radiologists in objectively assigning BI-RADS classifications and assessing the likelihood of malignancy (LOM). The Imagio system aims to increase diagnostic confidence, reduce the number of unnecessary biopsies, and streamline the breast cancer diagnostic pathway without using ionizing radiation or contrast agents.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Opto-Acoustic/Ultrasound (OA/US) technology for fused functional and anatomical imaging
- AI-driven clinical decision support tool (SenoGramu00ae) for objective BI-RADS classification and LOM assessment
- Real-time imaging to differentiate malignant and benign breast tissue
- Non-invasive, no ionizing radiation, and no contrast agents
- Designed to reduce unnecessary breast biopsies and diagnostic workups
- Provides information on blood oxygenation and vascularity within breast masses
- Suitable for assessment of BI-RADS 3, 4a, and 4b masses
- Demonstrated improved specificity without significant loss of sensitivity
- Capable of differentiating masses as small as 3.5 mm
- Enhances diagnostic confidence for clinicians at the point of care
Use Cases
- Diagnostic evaluation of palpable and non-palpable breast lesions
- Reducing false positive breast biopsies
- Assessing and refining BI-RADS classifications
- Adjunctive imaging for suspicious areas identified by mammography or ultrasound
- Differentiating benign from malignant breast tissue without invasive procedures
- Improving diagnostic confidence and efficiency in breast cancer care pathways
What Physicians Need to Know
Leverage the SenoGram® AI decision-support tool to objectively assess the likelihood of malignancy, which can enhance diagnostic accuracy and confidence. The system's ability to provide real-time functional and anatomical information without radiation or contrast agents can significantly reduce patient anxiety and potentially avoid unnecessary biopsies. Integrate the Imagio system into existing workflows, as it is designed for minimal disruption, and utilize the provided training and certification to maximize its benefits.
The Imagio Breast Imaging System is designed to integrate into existing diagnostic workflows without requiring changes to screening protocols or replacing biopsy when clinically indicated. Its adoption is compared to the implementation of tomosynthesis, suggesting a familiar integration process for imaging centers.
Details
| Category | Oncology AI, Radiology & Imaging AI |
| Pricing | Contact for pricing |
| Deployment | On-premise (medical imaging system) |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | General Surgery, Oncology, Radiology |
Support & Reliability
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2021-01-11 | P200003 PMA | Imagio Breast Imaging System |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Imagio Breast Imaging System
Videos
Product demos, reviews, and walkthroughs for Imagio Breast Imaging System.





